Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Commentary

Commentary
Challenges of Identifying Allergies to Inactive Ingredients
01/04/2022
"Regulations for the disclosure of color additives are confusing at best. Health care practitioners must assume the responsibility of ensuring all potential allergens are identified prior to dispensing and administration," writes Merissa...
"Regulations for the disclosure of color additives are confusing at best. Health care practitioners must assume the responsibility of ensuring all potential allergens are identified prior to dispensing and administration," writes Merissa...
"Regulations for the disclosure...
01/04/2022
Pharmacy Learning Network

Advertisement

Headshot of Ann Latner, JD
Commentary
Pharmacy Law: Massachusetts Attorney General Questions Pharmacies on Patient Vaccine Data Use
12/13/2021
Ann W Latner, JD, reviews a legal proceeding in which an attorney general contacted retail pharmacy executives with concerns over personal data being collected from patients receiving COVID-19 vaccinations.
Ann W Latner, JD, reviews a legal proceeding in which an attorney general contacted retail pharmacy executives with concerns over personal data being collected from patients receiving COVID-19 vaccinations.
Ann W Latner, JD, reviews a...
12/13/2021
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
Updates on Atrial Fibrillation Causation: Omega-3 Fatty Acids, Diabetes, and More
12/08/2021
​​​​​​​In this commentary, Mark Munger, PharmD, discusses recently published studies related to atrial fibrillation and advises pharmacists to be cognizant of patient risk factors.
​​​​​​​In this commentary, Mark Munger, PharmD, discusses recently published studies related to atrial fibrillation and advises pharmacists to be cognizant of patient risk factors.
​​​​​​​In this commentary, Mark...
12/08/2021
Pharmacy Learning Network
Commentary
The Diabetes Epidemic: Urgent Need to Emphasize Prevention, Detection, Management of Type 2 Diabetes
12/02/2021
“…it is imperative that clinicians—including pharmacists—expand patient education initiatives to augment awareness about the serious health consequences associated with diabetes," writes Yvette C Terrie, BS Pharm.
“…it is imperative that clinicians—including pharmacists—expand patient education initiatives to augment awareness about the serious health consequences associated with diabetes," writes Yvette C Terrie, BS Pharm.
“…it is imperative that...
12/02/2021
Pharmacy Learning Network

Advertisement

ann latner
Commentary
Pharmacy Law: Physician Sues CVS for Refusing to Fill His Prescriptions
11/30/2021
Ann W Latner, JD, cites key takeaways from recent legal proceedings that involved a pharmacy’s refusal to fill opioid prescriptions.
Ann W Latner, JD, cites key takeaways from recent legal proceedings that involved a pharmacy’s refusal to fill opioid prescriptions.
Ann W Latner, JD, cites key...
11/30/2021
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
Stimulant Use in Older Adults May Increase Cardiovascular Risk
11/22/2021
Mark Munger, PharmD, advises pharmacists to speak with prescribing physicians about the potential cardiovascular risks associated with stimulant use for older adults.
Mark Munger, PharmD, advises pharmacists to speak with prescribing physicians about the potential cardiovascular risks associated with stimulant use for older adults.
Mark Munger, PharmD, advises...
11/22/2021
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
Association Between Part-Time Clinical Work and Patient Outcomes: A Pharmacy Perspective
11/16/2021
"As the field moves toward a greater clinical focus, pharmacists need to study patient outcomes constantly and consistently in a longitudinal manner, not only to understand the impact of part-time vs full-time work, but also to justify...
"As the field moves toward a greater clinical focus, pharmacists need to study patient outcomes constantly and consistently in a longitudinal manner, not only to understand the impact of part-time vs full-time work, but also to justify...
"As the field moves toward a...
11/16/2021
Pharmacy Learning Network

Advertisement

Commentary
Education Alone Is Ineffective at Improving Provider Skills
11/04/2021
"Instead of using education as the only strategy to reduce the risk of errors, it should be layered with higher leverage strategies that improve system reliability," says Jill Paslier, PharmD, CSP, about improving health care practitioners'...
"Instead of using education as the only strategy to reduce the risk of errors, it should be layered with higher leverage strategies that improve system reliability," says Jill Paslier, PharmD, CSP, about improving health care practitioners'...
"Instead of using education as...
11/04/2021
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
Low-Dose Quadruple Therapy for Hypertension
10/28/2021
“Do not be surprised if a quadpill becomes available in the US soon for hypertension,” says Mark Munger, PharmD.
“Do not be surprised if a quadpill becomes available in the US soon for hypertension,” says Mark Munger, PharmD.
“Do not be surprised if a...
10/28/2021
Pharmacy Learning Network
Commentary
Taking a Stand Against Cancer: Early Detection and Intervention With Innovative Therapies Brings Hope
10/26/2021
“As pharmacists, we can not only provide cancer patients with information about possible therapies, but also direct them to various patient education resources and encourage them to take an active role in their cancer treatment plan and in...
“As pharmacists, we can not only provide cancer patients with information about possible therapies, but also direct them to various patient education resources and encourage them to take an active role in their cancer treatment plan and in...
“As pharmacists, we can not only...
10/26/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use